Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Phillip Scheinberg, Olga Nunez, Barbara Weinstein, Priscila Scheinberg, Colin O. Wu, Neal S. Young

Blood (2012) 119 (2): 345–354.

https://doi.org/10.1182/blood-2011-05-352328

Published: 2012

Includes: Supplemental data

Journal Articles

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Phillip Scheinberg, MD, Olga Nunez, RN, Priscila Scheinberg, MS, CCRP, Barbara Weinstein, RN, Colin O. Wu, PhD, Neal S. Young, MD

Blood (2011) 118 (21): 2406.

https://doi.org/10.1182/blood.V118.21.2406.2406

Published: 2011

Journal Articles

Serum Sickness and Plasma Cytokine Profiles After Treatment with Antithymocyte Globulin In Severe Aplastic Anemia Patients.

Xingmin Feng, PhD, Phillip Scheinberg, MD, Olga Nunez, Angelique Biancotto, Tomoiku Takaku, J. Philip McCoy, PhD, Neal S. Young, MD

Blood (2010) 116 (21): 1162.

https://doi.org/10.1182/blood.V116.21.1162.1162

Published: 2010

Journal Articles

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, CCRP, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): 1167.

https://doi.org/10.1182/blood.V116.21.1167.1167

Published: 2010

Journal Articles

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, Barbara Weinstein, RN, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): LBA-4.

https://doi.org/10.1182/blood.V116.21.LBA-4.LBA-4

Published: 2010

Journal Articles

Th17 immune responses contribute to the pathophysiology of aplastic anemia

Regis Peffault de Latour, Valeria Visconte, Tomoiku Takaku, Colin Wu, Andrew J. Erie, Annahita K. Sarcon, Marie J. Desierto, Phillip Scheinberg, Keyvan Keyvanfar, Olga Nunez, Jichun Chen, Neal S. Young

Blood (2010) 116 (20): 4175–4184.

https://doi.org/10.1182/blood-2010-01-266098

Published: 2010

Includes: Supplemental data

Journal Articles

Endoplasmic Reticulum Stress Is a Target for Therapy in Paroxysmal Nocturnal Hemoglobinuria.

Regis Peffault de Latour, MD, PhD, Valeria Visconte, PhD, Keyvan Keyvanfar, Olga Nunez, Marie Desierto, Jichun Chen, PhD, Adrian Wiestner, MD, PhD, Neal S Young, MD

Blood (2009) 114 (22): 160.

https://doi.org/10.1182/blood.V114.22.160.160

Published: 2009

Journal Articles

Plasma Cytokines Associated with Low Platelet Counts in Aplastic Anemia and Immune Thrombocytopenia.

Xingmin Feng, PhD, Phillip Scheinberg, MD, Leigh Samsel, Olga Nunez, Spencer Green, J. Philip McCoy, Jr., PhD, James B. Bussel, MD, Neal S. Young, MD

Blood (2009) 114 (22): 1317.

https://doi.org/10.1182/blood.V114.22.1317.1317

Published: 2009

Journal Articles

Differential Gene Expression Profile in the T Cell Compartment Between Classic PNH and Aplastic Anemia/PNH Syndrome.

Valeria Visconte, PhD, Regis Peffault de Latour, MD, PhD, Nalini Raghavachari, PhD, Delong Liu, PhD, Keyvan Keyvanfar, Olga Nunez, Neal S Young, MD

Blood (2009) 114 (22): 3011.

https://doi.org/10.1182/blood.V114.22.3011.3011

Published: 2009

Journal Articles

Circulating Cytokine Profiles of Patients with Acquired Aplastic Anemia and Myelodysplastic Syndrome

Xingmin Feng, PhD, Phillip Scheinberg, MD, Colin O. Wu, PhD, Leigh Samsel, Olga Nunez, Courtney Prince, Barbara Weinstein, Rebecca D Ganetzky, B.A., J. Philip McCoy, PhD, Jaroslaw P. Maciejewski, MD, PhD, Neal S. Young, MD

Blood (2008) 112 (11): 1038.

https://doi.org/10.1182/blood.V112.11.1038.1038

Published: 2008

Journal Articles

Predicting Response and Survival for Severe Aplastic Anemia Patients Treated with Immunosuppression.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal S. Young, MD

Blood (2007) 110 (11): 1691.

https://doi.org/10.1182/blood.V110.11.1691.1691

Published: 2007

Journal Articles

Long Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Anti-Thymocyte Globulin and Cyclosporine.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal Young, MD

Blood (2007) 110 (11): 1694.

https://doi.org/10.1182/blood.V110.11.1694.1694

Published: 2007

Journal Articles

Marked Improvement in Short- and Long-Term Survival in Severe Aplastic Anemia Patients Treated with Immunosuppression in the Past 18 Years.

Phillip Scheinberg, MD, Colin O. Wu, PhD, Olga Nunez, RN, Neal S. Young, MD

Blood (2007) 110 (11): 1698.

https://doi.org/10.1182/blood.V110.11.1698.1698

Published: 2007

Journal Articles

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

Phillip Scheinberg, Steven H. Fischer, Li Li, Olga Nunez, Colin O. Wu, Elaine M. Sloand, Jeffrey I. Cohen, Neal S. Young, A. John Barrett

Blood (2006) 109 (8): 3219–3224.

https://doi.org/10.1182/blood-2006-09-045625

Published: 2006

Journal Articles

Subclinical EBV and CMV Reactivations Commonly Occur Following Antibody-Based Immunosuppressive Regimens for Patients with Severe Aplastic Anemia.

Phillip Scheinberg, MD, Stephen H. Fischer, PhD, Li Li, Olga Nunez, RN, Colin O. Wu, Neal S. Young, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1428.

https://doi.org/10.1182/blood.V106.11.1428.1428

Published: 2005

Journal Articles

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG), Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF).

Phillip Scheinberg, MD, Olga Nunez, RN, Colin O. Wu, Neal S. Young, MD

Blood (2005) 106 (11): 3758.

https://doi.org/10.1182/blood.V106.11.3758.3758

Published: 2005

Journal Articles

T-bet Over-Expression in T Cells from Patients with Aplastic Anemia.

Elena E. Solomou, MD, Keyvan Keyvanfar, Elaine M. Sloand, MD, Barbara Weinstein, Olga Nunez, Neal S. Young, MD

Blood (2005) 106 (11): 832.

https://doi.org/10.1182/blood.V106.11.832.832

Published: 2005

Journal Articles

Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers

Weihua Zeng, Guibin Chen, Sachiko Kajigaya, Olga Nunez, Alexandra Charrow, Eric M. Billings, Neal S. Young

Blood (2004) 103 (1): 325–332.

https://doi.org/10.1182/blood-2003-02-0490

Published: 2004

Journal Articles

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia

Jaroslaw P. Maciejewski, Elaine M. Sloand, Olga Nunez, Carol Boss, Neal S. Young

Blood (2003) 102 (10): 3584–3586.

https://doi.org/10.1182/blood-2003-04-1032

Published: 2003

Journal Articles

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome

Hiroki Yamaguchi, Gabriela M. Baerlocher, Peter M. Lansdorp, Stephen J. Chanock, Olga Nunez, Elaine Sloand, Neal S. Young

Blood (2003) 102 (3): 916–918.

https://doi.org/10.1182/blood-2003-01-0335

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Serum Sickness and Plasma Cytokine Profiles After Treatment with Antithymocyte Globulin In Severe Aplastic Anemia Patients.

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Th17 immune responses contribute to the pathophysiology of aplastic anemia

Endoplasmic Reticulum Stress Is a Target for Therapy in Paroxysmal Nocturnal Hemoglobinuria.

Plasma Cytokines Associated with Low Platelet Counts in Aplastic Anemia and Immune Thrombocytopenia.

Differential Gene Expression Profile in the T Cell Compartment Between Classic PNH and Aplastic Anemia/PNH Syndrome.

Circulating Cytokine Profiles of Patients with Acquired Aplastic Anemia and Myelodysplastic Syndrome

Predicting Response and Survival for Severe Aplastic Anemia Patients Treated with Immunosuppression.

Long Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Anti-Thymocyte Globulin and Cyclosporine.

Marked Improvement in Short- and Long-Term Survival in Severe Aplastic Anemia Patients Treated with Immunosuppression in the Past 18 Years.

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

Subclinical EBV and CMV Reactivations Commonly Occur Following Antibody-Based Immunosuppressive Regimens for Patients with Severe Aplastic Anemia.

Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG), Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF).

T-bet Over-Expression in T Cells from Patients with Aplastic Anemia.

Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia

Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only